Stock market crash: 2 bargain UK shares I’d buy in an ISA today to retire in comfort

These two bargain UK shares could offer long-term total return potential after the market crash. They could help to boost your retirement prospects.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Buying UK shares to retire in comfort may not sound like an appealing idea to many investors after the market crash. After all, valuations across the FTSE 100 and FTSE 250 have come under severe pressure due to a weak economic outlook.

However, buying high-quality UK shares now while they offer good value for money could be a shrewd move. You may benefit from the stock market’s likely recovery in the coming years.

With that in mind, here are two stocks that could be worth buying in an ISA today. They could help you to retire in comfort.

AstraZeneca: a defensive ally in a market crash

While many UK shares have struggled to post gains in 2020 due to the market crash, AstraZeneca’s (LSE: AZN) share price has moved 8% higher since the start of the year. This may be due in part to its strong recent results. For example, in the first half of its financial year, the company grew its total revenue by 14%, while its core earnings per share moved 26% higher.

The prospects for the stock appear to be positive. Its investment in new drugs seems to be catalysing its financial performance. And, since its sales and profitability are less closely aligned to the economic outlook than many UK shares, it could offer defensive characteristics.

Given that there’s an ongoing threat of a second market crash, AstraZeneca’s growth potential in difficult economic conditions could increase demand for its shares. Although it trades on a price-to-earnings (P/E) ratio of around 27, its 27% earnings growth forecast for next year could mean it offers good value for money. As such, now could be the right time to buy a slice of it for the long run.

Morrisons: a FTSE 100 stock with long-term growth potential

Even though the Morrisons (LSE: MRW) share price is down 3% in 2020 as a result of the market crash, it’s held up better than many UK shares. Of course, rising demand for groceries has helped to strengthen its recent financial performance. For example, the company reported like-for-like sales growth of 5.7% in the first quarter of its financial year.

Looking ahead, Morrisons seems to be in a good position to maintain a relatively high rate of growth. For example, it’s rapidly expanding its online presence. This could allow it to capitalise on what may prove to be a permanent shift towards online grocery delivery or collection for many UK consumers.

Certainly, weak consumer confidence and a competitive marketplace could hold back Morrisons’ share price. It also faces the threat of a second market crash.

However, compared to most UK shares, it’s experiencing strong demand for its products. And, with a solid strategy, it could outperform the wider stock market in the coming years.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Peter Stephens owns shares of AstraZeneca and Morrisons. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »